Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart L Scott

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
JAMA Oncology|July 17, 2015
JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?Bart L Scott, Pamela S Becker
Archivum Immunologiae Et Therapiae Experimentalis|August 10, 2005
Hemopoietic cell transplantation for the myelodysplastic syndromesBart L Scott, H Joachim Deeg
Hematology. American Society of Hematology. Education Program|November 25, 2006
Outcomes with myeloid malignanciesBart L Scott, Brenda M Sandmaier
American Journal of Hematology|March 3, 2018
Allogeneic transplantation for myelofibrosis with adverse risk karyotype: Attack on the clones?Jason P Cooper, Bart L Scott
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemiaAaron T Gerds, Matthew J Walter, Bart L Scott
Current Opinion in Hematology|October 10, 2013
Transplantation for myelodysplastic syndromes 2013Jennifer E Vaughn, Bart L Scott, H Joachim Deeg
Blood Advances|June 10, 2025
A cure for the kiss of death?Jacob S Appelbaum, Mary-Elizabeth Percival, Bart L Scott
The Oncologist|October 15, 2015
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiaChristopher R Cogle, Bart L Scott, Thomas Boyd, et al.
Journal of Clinical Pharmacology|December 31, 2013
Pharmacokinetics of different formulations of oral azacitidine (CC-486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignanciesEric Laille, Michael R Savona, Bart L Scott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndromeBart L Scott, Barry Storer, Michael R Loken, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
JAMA Oncology|July 17, 2015
JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?Bart L Scott, Pamela S Becker
Archivum Immunologiae Et Therapiae Experimentalis|August 10, 2005
Hemopoietic cell transplantation for the myelodysplastic syndromesBart L Scott, H Joachim Deeg
Hematology. American Society of Hematology. Education Program|November 25, 2006
Outcomes with myeloid malignanciesBart L Scott, Brenda M Sandmaier
American Journal of Hematology|March 3, 2018
Allogeneic transplantation for myelofibrosis with adverse risk karyotype: Attack on the clones?Jason P Cooper, Bart L Scott
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemiaAaron T Gerds, Matthew J Walter, Bart L Scott
Current Opinion in Hematology|October 10, 2013
Transplantation for myelodysplastic syndromes 2013Jennifer E Vaughn, Bart L Scott, H Joachim Deeg
Blood Advances|June 10, 2025
A cure for the kiss of death?Jacob S Appelbaum, Mary-Elizabeth Percival, Bart L Scott
The Oncologist|October 15, 2015
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiaChristopher R Cogle, Bart L Scott, Thomas Boyd, et al.
Journal of Clinical Pharmacology|December 31, 2013
Pharmacokinetics of different formulations of oral azacitidine (CC-486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignanciesEric Laille, Michael R Savona, Bart L Scott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndromeBart L Scott, Barry Storer, Michael R Loken, et al.
Pageof 12